UBS Biotech Private Company Event

Published on 01/10/2021

Virtual Event
September 22-23, 2021

Jacky Vonderscher, our CEO, gave a talk during the plenary of the UBS Biotech Private Company Event.

Read next in 'Events'

• The 2024 international workshop on Alport syndrome
• ENYO Pharma annonce un financement de Série C de 39 millions d'euros et l’autorisation de la FDA (IND) pour tester Vonafexor dans un essai clinique de Phase 2 pour les patients atteints du syndrome d'Alport
• 6th CKD Summit – Chronic Kidney Disease Drug Development
• ASN Kidney Week
• Alport Connect 2023, the annual Alport syndrome patient and family meeting in US